Health Equity in Chronic Liver Diseases in the United States
Nov
2026
Description
This session presents current research on health disparities and health equity in chronic liver diseases in the United States. Topics include disparities in treatment access, rural versus urban outcomes, the role of social determinants of health in surveillance and therapy, patient portal engagement, and shifting drivers of liver cancer.
Presentations
2:00 PM
- 2:15 PM
Convention Center - Mile High Ballroom 2B-3B
Unequal Access to Curative Therapy: Racial and Ethnic Disparities in Direct-Acting Antiviral Treatment for Chronic Hepatitis C in the United States
ABBAS R SYED, MD | Abstract Presenter
2:15 PM
- 2:30 PM
Convention Center - Mile High Ballroom 2B-3B
Same Disease, Different Hospital: Rural vs. Urban Outcomes In Alcohol-Associated Hepatitis
Het Patel, DO | Abstract Presenter
2:30 PM
- 2:45 PM
Convention Center - Mile High Ballroom 2B-3B
Social Determinants of Health and HCC Surveillance Receipt in Patients with Cirrhosis: A Multicenter Cohort Study
Mohammed Al-Hasan, MD | Abstract Presenter
2:45 PM
- 3:00 PM
Convention Center - Mile High Ballroom 2B-3B
Disparities in Electronic Health Record Patient Portal Engagement Among Adults With Cirrhosis: An Epic Cosmos Study
Oren K Fix, MD, MSc, FAASLD | Abstract Presenter
3:00 PM
- 3:15 PM
Convention Center - Mile High Ballroom 2B-3B
Metabolic Dysfunction-Associated Steatohepatitis (MASH) Outpacing Alcohol-Associated Liver Disease (ALD) as the Principal Driver of Rising Steatotic Liver Disease-Associated Liver Cancer
Eliabe S. Abreu, MD | Abstract Presenter
3:15 PM
- 3:30 PM
Convention Center - Mile High Ballroom 2B-3B
Social Determinants of Health, Rather Than Disease Severity, Drive Second-Line Therapy Escalation in Primary Biliary Cholangitis
Liliana Vittini-Hernandez, MD | Abstract Presenter
